Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly – A meta-analysis

BACKGROUND: Metformin is the first-choice drug for patients with Type 2 diabetes, and this therapy is characterized by being weight neutral. However, in the elderly an additional unintentional weight loss could be considered as an adverse effect of the treatment. OBJECTIVES: We aimed to perform a me...

Descripción completa

Detalles Bibliográficos
Autores principales: Solymár, Margit, Ivic, Ivan, Pótó, László, Hegyi, Péter, Garami, András, Hartmann, Petra, Pétervári, Erika, Czopf, László, Hussain, Alizadeh, Gyöngyi, Zoltán, Sarlós, Patrícia, Simon, Mária, Mátrai, Péter, Bérczi, Bálint, Balaskó, Márta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258123/
https://www.ncbi.nlm.nih.gov/pubmed/30475888
http://dx.doi.org/10.1371/journal.pone.0207947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258123/
https://www.ncbi.nlm.nih.gov/pubmed/30475888
http://dx.doi.org/10.1371/journal.pone.0207947

Ejemplares similares